You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Histologically proven locally advanced or metastatic high grade STS (excluding histologies insensitive to chemotherapy such as ASPS, PECOMA subtypes)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sarcoma, Soft Tissue Trial in Worldwide (Trabectedin)

Terminated
  • Sarcoma, Soft Tissue
  • Bordeaux, France
  • +13 more
Sep 1, 2020

NSCLC Trial in Worldwide (Atezolizumab, Tiragolumab, Placebo)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • Tempe, Arizona
  • +40 more
Nov 11, 2022

Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation

Not yet recruiting
  • Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation Sequencing (NGS) Panel (>30 Genes)
  • Minimal documentation
  • Extended documentation
  • Mannheim, Baden-Württemberg, Germany
  • +1 more
Jan 18, 2023

Advanced Solid Tumors Trial in Australia, China (Sitravatinib)

Completed
  • Advanced Solid Tumors
  • Blacktown, New South Wales, Australia
  • +16 more
Jan 10, 2023

Localized Leiomyosarcoma Biomarker Protocol

Not yet recruiting
  • Leiomyosarcoma
  • Blood and Tissue collection
  • Ann Arbor, Michigan
  • +3 more
Jan 5, 2023

Sarcoma Trial in Seoul (Durvalumab+doxorubicin cobination)

Active, not recruiting
  • Sarcoma
  • Durvalumab+doxorubicin cobination
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
May 30, 2022

TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Alkaline Glucosodiene Molecules
  • (no location specified)
Jul 14, 2023

Unresectable Locally Advanced Urothelial Cancer, Metastatic Urothelial Cancer Trial in Worldwide (Durvalumab, Tremelimumab,

Recruiting
  • Unresectable Locally Advanced Urothelial Cancer
  • Metastatic Urothelial Cancer
  • Birmingham, Alabama
  • +237 more
Aug 18, 2022

Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Leiomyosarcoma Trial in Toronto (Selinexor)

Recruiting
  • Soft Tissue Sarcoma
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 7, 2022

Large-Cell Neuroendocrine Carcinoma Trial in Lexington (Treatment Specific for Non-Small Cell Carcinoma/Adenocarcinoma,

Recruiting
  • Large-Cell Neuroendocrine Carcinoma
  • Treatment Specific for Non-Small Cell Carcinoma/Adenocarcinoma
  • Treatment for Small Cell Lung Cancer
  • Lexington, Kentucky
    Markey Cancer Center, University of Kentucky
Jan 12, 2022

NSCLC Trial in Shanghai (SI-B001, SI-B003)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 10, 2023

Advanced Sarcoma, Metastatic Sarcoma, Soft Tissue Sarcoma Trial (YH001, Envafolimab, Doxorubicin)

Recruiting
  • Advanced Sarcoma
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Center
Dec 5, 2022

pMMR, MSS, MSI-L Trial (Serplilumab, Capecitabine, Oxaliplatin)

Not yet recruiting
  • pMMR
  • +3 more
  • (no location specified)
Feb 19, 2023

Triple-Negative Breast Cancer Trial in Worldwide (Atezolizumab, Nab-Paclitaxel)

Active, not recruiting
  • Triple-Negative Breast Cancer
  • Buenos Aires, Argentina
  • +75 more
Nov 21, 2022

Esophageal Squamous Cell Carcinoma Trial in Xi'an (Tislelizumab + cisplatin + paclitaxel, Tislelizumab + radiotherapy)

Enrolling by invitation
  • Esophageal Squamous Cell Carcinoma
  • Tislelizumab + cisplatin + paclitaxel
  • Tislelizumab + radiotherapy
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of Xi'an Jiaotong University
Dec 21, 2022

Breast Cancer, Breast Tumors, Breast Cancer Female Trial in Istanbul (Axillary sentinal lymph node biopsy)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Axillary sentinal lymph node biopsy
  • İstanbul, Bagcilar, Turkey
  • +1 more
Oct 22, 2023

Locally Advanced or Metastatic NSCLC Trial in China (AK104, Tislelizumab, carboplatin)

Not yet recruiting
  • Locally Advanced or Metastatic NSCLC
  • Bengbu, Anhui, China
  • +61 more
Aug 10, 2023

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation Trial in Canton (TAS6417)

Recruiting
  • Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
  • Canton, Ohio
    Gabrail Cancer and Research Center
Jul 25, 2023

Carcinoid Tumor of the Small Bowel, Neuroendocrine Tumour Trial in Worldwide (Octreotide LAR, 177Lu-DOTA0-Tyr3-Octreotate)

Completed
Has Results
  • Carcinoid Tumor of the Small Bowel
  • Neuroendocrine Tumour
  • Los Angeles, California
  • +38 more
Mar 10, 2022

PD-L1-selected Solid Tumors Trial in Spokane (Tiragolumab and Atezolizumab IV FDC)

Recruiting
  • PD-L1-selected Solid Tumors
  • Tiragolumab and Atezolizumab IV FDC
  • Spokane, Washington
    Medical Oncology Associates
Jan 13, 2023

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Mar 20, 2023

Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,

Not yet recruiting
  • Esophageal Cancer
  • +2 more
  • (no location specified)
Aug 21, 2023

Non-metastatic Soft-tissue Sarcoma, Resectable Trial in France (Doxorubicin, Ifosfamide or dacarbazine, At the discretion of the

Recruiting
  • Non-metastatic Soft-tissue Sarcoma
  • Resectable
  • Bordeaux, France
  • +9 more
Jul 27, 2022

Cervical Cancer, Induction Chemo, Immunotherapy Trial in Tianjin (Toripalimab)

Recruiting
  • Cervical Cancer
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Oct 16, 2023

Soft Tissue Sarcoma, Bone Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Iowa City (Ascorbate, Gemcitabine)

Not yet recruiting
  • Soft Tissue Sarcoma
  • +5 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Sep 16, 2022